Recently, studies have shown that inhibition of PARP1 alleviates hypercholesterolemia and steatohepatitis in mice, implicating a potential role of PARP1 in the pathogenesis of cholesterol disorders 21. The gene discussed is PARP1; the disease is familial hypercholesterolemia.